Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
Podcast
When Life Gets in the Way of RTW
One of the perplexing mysteries of workers’ comp is when a solid return-to-work plan doesn’t come to fruition.
Workers' Comp
News Release
Data could prompt comp industry to reconsider chiropractors
The average medical cost-per-claim for injured workers with lower back pain who were treated exclusively by a chiropractor was 61% less than for th
Business Insurance
News Release
Prescriptions for Opioid Disorder Meds on Rise in Comp
Auto Physical Damage
Article
Average Length of Rental for Repairable Vehicles: Q1 2022
U.S.
Business Insurance
News Release
Prescriptions for Opioid Disorder Meds on Rise in Comp
Workers' Comp
News Release
Enlyte Names Steve Laudermilch EVP of Mitchell Casualty Solutions
P&C executive will head company’s auto casualty and workers’ comp technology division.